The US Supreme Court has temporarily restored broad access to the abortion pill mifepristone, blocking a lower-court ruling that would have tightened how the drug can be obtained.The order allows women seeking abortions to continue getting the pill at pharmacies or by mail, without an in-person visit to a doctor.The restrictions had been imposed by a federal appeal court last week.The decision preserves a system that has been in place for several years and avoids an immediate change to how the medication is dispensed.Mifepristone is usually used with misoprostol, and medication abortions account for most abortions in the US.The ruling... [Continue Reading]
The Fifth Circuit Court of Appeals has temporarily reinstated a requirement that abortion pills, specifically mifepristone, must be obtained in person rather than by mail or telemedicine.This decision significantly limits access to the abortion pill in states where abortion is banned.The ruling stems from a lawsuit filed by the state of Louisiana and pauses a 2023 Food and Drug Administration (FDA) regulation that allowed doctors to send mifepristone without an in-person consultation.The court stated that the FDA's previous action undermined Louisiana's policy that every unborn child is a legal person from conception.Mifepristone is the first of a two-pill regimen recommended... [Continue Reading]